Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|November 7, 2013
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsGuglielmo Ronco, Joakim Dillner, K Miriam Elfström, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2016
Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global ScaleDavid Gaffney, Bill Small, Henry Kitchener, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2015
Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal AntibodiesJoshua W Wang, Subhashini Jagu, Wai-Hong Wu, et al.
BMJ (Clinical Research Ed.)|February 8, 2019
Primary cervical screening with high risk human papillomavirus testing: observational studyMatejka Rebolj, Janet Rimmer, Karin Denton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
First-line therapy in ovarian cancer trialsTate Thigpen, Andreas duBois, Jessica McAlpine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancerJonathan A Ledermann, Christian Marth, Mark S Carey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 17, 2015
Advances and Concepts in Cervical Cancer Trials: A Road Map for the FutureSatoru Sagae, Bradley J Monk, Eric Pujade-Lauraine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
Clinical trials in recurrent ovarian cancerMichael Friedlander, Edward Trimble, Anna Tinker, et al.
Pageof 5